![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Resistance and Potency of GS-7340, a Next-Generation Tenofovir Prodrug
|
|
|
Reported by Jules Levin
International Workshop on HIV &
Hepatitis Virus Drug Resistance and Curative
Strategies
June 5-9, 2012
Sitges, Spain
C Callebaut, N Margot and M Miller
Gilead Sciences, Inc., Foster City, CA, USA
![HIVHCVResist1.gif](../images/061512/051512-5/HIVHCVResist1.gif)
![HIVHCVResist2.gif](../images/061512/051512-5/HIVHCVResist2.gif)
![HIVHCVResist3.gif](../images/061512/051512-5/HIVHCVResist3.gif)
![HIVHCVResist4.gif](../images/061512/051512-5/HIVHCVResist4.gif)
![HIVHCVResist5.gif](../images/061512/051512-5/HIVHCVResist5.gif)
![HIVHCVResist6.gif](../images/061512/051512-5/HIVHCVResist6.gif)
![HIVHCVResist7.gif](../images/061512/051512-5/HIVHCVResist7.gif)
![HIVHCVResist8.gif](../images/061512/051512-5/HIVHCVResist8.gif)
![HIVHCVResist9.gif](../images/061512/051512-5/HIVHCVResist9.gif)
![HIVHCVResist10.gif](../images/061512/051512-5/HIVHCVResist10.gif)
![HIVHCVResist11.gif](../images/061512/051512-5/HIVHCVResist11.gif)
![HIVHCVResist12.gif](../images/061512/051512-5/HIVHCVResist12.gif)
![HIVHCVResist13.gif](../images/061512/051512-5/HIVHCVResist13.gif)
![HIVHCVResist14.gif](../images/061512/051512-5/HIVHCVResist14.gif)
![HIVHCVResist15.gif](../images/061512/051512-5/HIVHCVResist15.gif)
![HIVHCVResist16.gif](../images/061512/051512-5/HIVHCVResist16.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|